Ensign Peak Advisors, Inc Oncorus, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.44 - $5.62 $54,720 - $213,560
-38,000 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$5.03 - $11.63 $186,110 - $430,310
-37,000 Reduced 49.33%
38,000 $200,000
Q4 2020

Feb 12, 2021
BUY
$15.0 - $35.15 $1.13 Million - $2.64 Million
75,000 New
75,000 $2.43 Million

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email